A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses
about
A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Bioequivalence Study With Cl ...... ubjects With Actinic Keratoses
@en
type
label
A Bioequivalence Study With Cl ...... ubjects With Actinic Keratoses
@en
prefLabel
A Bioequivalence Study With Cl ...... ubjects With Actinic Keratoses
@en
P6153
P1050
P1476
A Multicenter, Randomized, Dou ...... ubjects With Actinic Keratoses
@en
P3098
NCT01502020
P4844
P580
2011-02-01T00:00:00Z
P582
2011-08-01T00:00:00Z